Related Experiment Video
Updated: Jun 19, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
A lymphotoxin-driven pathway to hepatocellular carcinoma
Johannes Haybaeck1, Nicolas Zeller, Monika Julia Wolf
1Department of Pathology, University Hospital Zurich, CH 8091 Zurich, Switzerland.
Hepatitis B and C viruses (HBV and HCV) cause liver cancer through poorly understood mechanisms. This study reveals that lymphotoxin (LT) signaling promotes hepatitis and hepatocellular carcinoma (HCC) development.
Area of Science:
- Hepatology
- Immunology
- Oncology
Background:
- Hepatitis B and C viruses (HBV and HCV) are major causes of chronic hepatitis and hepatocellular carcinoma (HCC).
- The precise molecular mechanisms underlying HBV/HCV-induced HCC remain incompletely understood.
- Cytokine signaling pathways are implicated in liver disease pathogenesis.
Purpose of the Study:
- To investigate the role of lymphotoxin (LT) cytokines and their receptor (LTbetaR) in HBV/HCV-induced hepatitis and HCC.
- To establish a causal link between hepatic LT overexpression and the development of liver inflammation and HCC.
- To identify key molecular players and signaling pathways involved in hepatitis-induced HCC.
Main Methods:
- Analysis of cytokine and receptor expression in HBV/HCV-infected liver tissues.
- Generation of transgenic mice with liver-specific expression of LTalpha and LTbeta.
- Assessment of liver inflammation, HCC development, and cellular composition in mouse models.
- Investigation of the dependence on lymphocytes, IKappa B kinase beta, and TNFR1 in HCC development.
- In vivo stimulation and inhibition of LTbetaR signaling.
Main Results:
- Lymphotoxin (LT) alpha and beta, along with their receptor (LTbetaR), are upregulated in HBV/HCV-induced hepatitis and HCC.
- Liver-specific expression of LTalpha/beta in mice leads to liver inflammation and HCC, establishing a causal link.
- HCC development in this model involves A6(+) oval cells and depends on lymphocytes and hepatocyte-expressed IKappa B kinase beta, but not TNFR1.
- Hepatocytes are identified as the primary LT-responsive liver cells upon in vivo LTbetaR stimulation.
- Inhibition of LTbetaR signaling in LTalpha/beta-transgenic mice with hepatitis significantly suppresses HCC formation.
Conclusions:
- Sustained lymphotoxin (LT) signaling is a critical pathway implicated in the pathogenesis of hepatitis-induced hepatocellular carcinoma (HCC).
- Targeting the LT signaling pathway may offer a therapeutic strategy for preventing or treating HCC in the context of chronic viral hepatitis.
- The study highlights the complex interplay between immune signaling and liver cell intrinsic pathways in driving HCC development.
Related Concept Videos
Cirrhosis II: Pathophysiology
The Intrinsic Apoptotic Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
